Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00056069
Other study ID # ACCL01P3
Secondary ID COG-ACCL01P3CDR0
Status Completed
Phase N/A
First received March 6, 2003
Last updated May 6, 2015
Start date December 2002
Est. completion date March 2010

Study information

Verified date May 2015
Source Children's Oncology Group
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

RATIONALE: Studying the physical and emotional needs of parents who are caring for children receiving chemotherapy for cancer may help doctors plan effective treatments for the patient that allow for improved quality of life of the patient's family.

PURPOSE: This clinical trial is studying the different physical and emotional needs of parents whose children are undergoing chemotherapy for acute lymphoblastic leukemia either in an outpatient clinic or in the hospital.


Description:

OBJECTIVES:

- Compare the caregiving demands reported by parents of children with acute lymphoblastic leukemia receiving methotrexate on 2 different infusion schedules (inpatient care vs outpatient care).

- Compare the change in caregiving demands on these parents over time, in terms of physical and emotional care, the need to make family arrangements, the need to communicate about the child's care, the need to gather information about the child's health status, and the effect on family well-being.

OUTLINE: Participants complete questionnaires regarding caregiver demands and family information over 25-30 minutes within 3-4 months of the initiation of the child's treatment and at the completion of the first year of the child's treatment.

PROJECTED ACCRUAL: A total of 164 participants will be accrued for this study within 0.8 years.


Recruitment information / eligibility

Status Completed
Enrollment 172
Est. completion date March 2010
Est. primary completion date January 2010
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility DISEASE CHARACTERISTICS:

- Parent or legal guardian who is the primary caregiver of a patient enrolled on COG-P9904 or COG-P9905 protocol

- Patient has not yet received week 13 of therapy

PATIENT CHARACTERISTICS:

Age

- Not specified

Performance status

- Not specified

Life expectancy

- Not specified

Hematopoietic

- Not specified

Hepatic

- Not specified

Renal

- Not specified

Other

- Able to understand English

PRIOR CONCURRENT THERAPY:

Biologic therapy

- Not specified

Chemotherapy

- Not specified

Endocrine therapy

- Not specified

Radiotherapy

- Not specified

Surgery

- Not specified

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
questionnaire administration
Participants complete questionnaires regarding caregiver demands and family information over 25-30 minutes within 3-4 months of the initiation of the child's treatment and at the completion of the first year of the child's treatment.

Locations

Country Name City State
Australia Royal Children's Hospital Brisbane Queensland
Australia Royal Children's Hospital Parkville Victoria
Australia Children's Hospital at Westmead Westmead New South Wales
Canada Alberta Children's Hospital Calgary Alberta
Canada Cross Cancer Institute at University of Alberta Edmonton Alberta
Canada McMaster Children's Hospital at Hamilton Health Sciences Hamilton Ontario
Canada Hopital Sainte Justine Montreal Quebec
Canada Montreal Children's Hospital at McGill University Health Center Montreal Quebec
Canada Children's Hospital of Eastern Ontario Ottawa Ontario
Canada Centre de Recherche du Centre Hospitalier de l'Universite Laval Sainte Foy Quebec
Canada Hospital for Sick Children Toronto Ontario
Netherlands University Medical Center Groningen Groningen
Puerto Rico San Jorge Children's Hospital Santurce
Switzerland Swiss Pediatric Oncology Group Bern Bern
Switzerland Swiss Pediatric Oncology Group Geneva Geneva
United States University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico
United States Mission Hospitals - Memorial Campus Asheville North Carolina
United States AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus Atlanta Georgia
United States MBCCOP-Medical College of Georgia Cancer Center Augusta Georgia
United States Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland
United States Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland
United States Pediatric Specialty Clinic at Eastern Maine Medical Center Bangor Maine
United States Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham Alabama
United States Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston Massachusetts
United States Floating Hospital for Children Boston Massachusetts
United States Massachusetts General Hospital Cancer Center Boston Massachusetts
United States Vermont Cancer Center at University of Vermont Burlington Vermont
United States Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina
United States West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division Charleston West Virginia
United States Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina
United States Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina
United States University of Virginia Cancer Center Charlottesville Virginia
United States Children's Memorial Hospital - Chicago Chicago Illinois
United States Rush University Medical Center Chicago Illinois
United States University of Missouri - Columbia Columbia Missouri
United States Driscoll Children's Hospital Corpus Christi Texas
United States Medical City Dallas Hospital Dallas Texas
United States Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas
United States Children's Hospital of Michigan Detroit Michigan
United States Van Elslander Cancer Center at St. John Hospital and Medical Center Detroit Michigan
United States Duke Comprehensive Cancer Center Durham North Carolina
United States INOVA Fairfax Hospital Falls Church Virginia
United States Hurley Medical Center Flint Michigan
United States Broward General Medical Center Cancer Center Fort Lauderdale Florida
United States Children's Hospital of Southwest Florida Fort Myers Florida
United States Cook Children's Medical Center - Fort Worth Fort Worth Texas
United States University of Florida Shands Cancer Center Gainesville Florida
United States University of Texas Medical Branch Galveston Texas
United States St. Vincent Hospital Green Bay Wisconsin
United States Children's Hospital of Greenville Hospital System Greenville South Carolina
United States Leo W. Jenkins Cancer Center at Pitt County Memorial Hospital Greenville North Carolina
United States Hackensack University Medical Center Hackensack New Jersey
United States Joe DiMaggio Children's Hospital at Memorial Hollywood Florida
United States Cancer Research Center of Hawaii Honolulu Hawaii
United States Tripler Army Medical Center Honolulu Hawaii
United States Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston Texas
United States University of Mississippi Medical Center Jackson Mississippi
United States Nemours Children's Clinic Jacksonville Florida
United States East Tennessee State University Cancer Center at Johnson City Medical Center Johnson City Tennessee
United States Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Kansas
United States Keesler Medical Center - Keesler Air Force Base Keesler AFB Mississippi
United States Rebecca and John Moores UCSD Cancer Center La Jolla California
United States Wilford Hall Medical Center Lackland Air Force Base Texas
United States Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire
United States Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas
United States CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin
United States St. Jude Children's Research Hospital Memphis Tennessee
United States Baptist-South Miami Regional Cancer Program Miami Florida
United States Miami Children's Hospital Miami Florida
United States University of Miami Sylvester Comprehensive Cancer Center Miami Florida
United States Midwest Children's Cancer Center Milwaukee Wisconsin
United States University of South Alabama Cancer Research Institute Mobile Alabama
United States Mary Babb Randolph Cancer Center at West Virginia University Hospitals Morgantown West Virginia
United States Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven Connecticut
United States Schneider Children's Hospital New Hyde Park New York
United States Children's Hospital of New Orleans New Orleans Louisiana
United States MBCCOP - LSU Health Sciences Center New Orleans Louisiana
United States Ochsner Cancer Institute at Ochsner Clinic Foundation New Orleans Louisiana
United States Tulane Cancer Center at Tulane University Hospital and Clinic New Orleans Louisiana
United States Beth Israel Medical Center - Singer Division New York New York
United States Mount Sinai Medical Center New York New York
United States Advocate Hope Children's Hospital Oak Lawn Illinois
United States Oklahoma University Medical Center Oklahoma City Oklahoma
United States Florida Hospital Cancer Institute Orlando Florida
United States Nemours Children's Clinic - Orlando Orlando Florida
United States Stanford Cancer Center at Stanford University Medical Center Palo Alto California
United States Sacred Heart Children's Hospital Pensacola Florida
United States Saint Jude Midwest Affiliate Peoria Illinois
United States St. Christopher's Hospital for Children Philadelphia Pennsylvania
United States CCOP - Columbia River Oncology Program Portland Oregon
United States Legacy Emanuel Hospital and Health Center & Children's Hospital Portland Oregon
United States Naval Medical Center - Portsmouth Portsmouth Virginia
United States Rhode Island Hospital Providence Rhode Island
United States Massey Cancer Center at Virginia Commonwealth University Richmond Virginia
United States Carilion Medical Center for Children at Roanoke Community Hospital Roanoke Virginia
United States James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York
United States Sutter Cancer Center Sacramento California
United States University of California Davis Cancer Center Sacramento California
United States Cardinal Glennon Children's Hospital Saint Louis Missouri
United States St. Louis Children's Hospital Saint Louis Missouri
United States MBCCOP - South Texas Pediatrics San Antonio Texas
United States University of Texas Health Science Center at San Antonio San Antonio Texas
United States Children's Hospital and Health Center - San Diego San Diego California
United States Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego San Diego California
United States Kaiser Permanente Medical Center - Santa Clara Kiely Campus Santa Clara California
United States Maine Children's Cancer Program Scarborough Maine
United States Walter Reed Army Medical Center Silver Spring Maryland
United States All Children's Hospital St. Petersburg Florida
United States Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York
United States SUNY Upstate Medical University Hospital Syracuse New York
United States Madigan Army Medical Center Tacoma Washington
United States St. Joseph's Children's Hospital of Tampa Tampa Florida
United States CCOP - Scott and White Hospital Temple Texas
United States Center for Cancer Prevention and Care at Scott and White Clinic Temple Texas
United States Arizona Cancer Center at University of Arizona Health Sciences Center Tucson Arizona
United States Natalie Warren Bryant Cancer Center at St. Francis Hospital Tulsa Oklahoma
United States Kaplan Cancer Center at St. Mary's Medical Center West Palm Beach Florida
United States CCOP - Wichita Wichita Kansas
United States Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas
United States Wesley Medical Center Wichita Kansas
United States Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina
United States UMASS Memorial Cancer Center - University Campus Worcester Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Children's Oncology Group National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Australia,  Canada,  Netherlands,  Puerto Rico,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Event Free Survival Length of study Yes
Secondary Determine whether caregivers whose child is randomized to receive the 24-hour methotrexate infusion will report lower caregiving demand than will caregivers whose child is randomized to receive the 4-hour infusion Length of study Yes
Secondary Total score from the CMCC Length of study No
See also
  Status Clinical Trial Phase
Recruiting NCT05691608 - MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 N/A
Recruiting NCT04092803 - Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu N/A
Active, not recruiting NCT02530463 - Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome Phase 2
Completed NCT00948064 - Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Phase 2
Completed NCT04474678 - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") N/A
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Recruiting NCT03948529 - RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation Phase 2
Completed NCT01682226 - Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies Phase 2
Completed NCT00003270 - Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer Phase 2
Active, not recruiting NCT02723994 - A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia Phase 2
Terminated NCT02469415 - Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) Phase 2
Recruiting NCT04856215 - 90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia Phase 2
Recruiting NCT06155188 - Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia N/A
Completed NCT00001637 - Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults Phase 2
Active, not recruiting NCT04188678 - Resiliency in Older Adults Undergoing Bone Marrow Transplant N/A
Completed NCT02910583 - Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) Phase 2
Completed NCT01212926 - Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain N/A
Terminated NCT00014560 - Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Phase 1
Recruiting NCT04977024 - SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer Phase 2
Recruiting NCT05866887 - Insomnia Prevention in Children With Acute Lymphoblastic Leukemia N/A